mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.4 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.4 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.4 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |